Edwards Lifesciences
EW
Delayed Nyse - 02/16 10:02:02 pm
133.82USD
-0.64%
Prev.134.6800
Open134.2700
High135.3300
Low133.3800
Volume1 506 410
Last news
Financials
Sales 2018 3 842 M
EBIT 2018 1 169 M
R. net 2018 936 M
Tréso. 2018 639 M
Rend. 2018 -
P/E ratio 2018 30,75
P/E ratio 2019 27,32
EV / Sales 2018 7,25x
EV / Sales 2019 6,48x
Capitalization 28 501 M
Company
Edwards Lifesciences Corp. engages in the design, development, manufacture, and markets products to treat stage cardiovascular disease.It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World.Its products are categorized into three areas: Surgical...
Sector :
Advanced Medical Equipment & Technology - NEC
Calendar :
No events available
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance135135151
Spread/Res.-0,64%-0,64%-11%
Spread/Supp.5,7%13%19%
Support127118112